News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
DMD Setback Prompts Sarepta to Shutter West Coast Location and Consolidate to Massachusetts, 30 Jobs Gone
March 9, 2016
·
3 min read
Policy
With Snowmageddon Predicted for East Coast, FDA Postpones Meeting Over Sarepta’s DMD Drug
January 21, 2016
·
2 min read
Policy
FDA Turns Down Both BioMarin and Sarepta’s DMD Drug Applications, Stocks Plunge
January 15, 2016
·
3 min read
Business
Checkmate Comes Out of Stealth Mode With $20 Million and Ex-Sarepta Exec as Its Leader
August 12, 2015
·
3 min read
Policy
Investors Gear Up For Exciting News as FDA Sets Dates for BioMarin and Sarepta DMD Drugs
July 21, 2015
·
2 min read
Deals
Sarepta and BioMarin Rivalry Heats Up as Sarepta Shops for Second DMD Drug
July 14, 2015
·
3 min read
Business
Sarepta Bags Ex-Genzyme CEO as Advisor to the Company
July 1, 2015
·
6 min read
Policy
New Sarepta CEO’s Strategy Bears Fruit With NDA Filing
June 30, 2015
·
5 min read
Business
EXCLUSIVE: Sarepta’s Interim CEO Doing Well Enough to Be Considered a Permanent Candidate, Company Tells BioSpace
June 2, 2015
·
7 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 31, 2020
July 31, 2020
·
2 min read
Business
Sarepta Therapeutics to Announce Second Quarter 2020 Financial Results and Recent Corporate Developments on August 5, 2020
July 29, 2020
·
1 min read
FDA
Sarepta Therapeutics Receives Fast Track Designation for SRP-9001 Micro-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
July 24, 2020
·
5 min read
Genetown
Sarepta Therapeutics Launches “Rare Lessons” Program to Promote Greater Diversity and Inclusion in the Classroom and Support Awareness of Rare Diseases
July 15, 2020
·
3 min read
Business
Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase
July 2, 2020
·
8 min read
Business
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
July 2, 2020
·
6 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2020
June 30, 2020
·
2 min read
Business
Sarepta Therapeutics Announces Retirement of Sandy Mahatme, Chief Financial Officer and Chief Business Officer
June 30, 2020
·
5 min read
Genetown
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
June 26, 2020
·
6 min read
Genetown
Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases
June 22, 2020
·
8 min read
